These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6460921)

  • 1. Hypersensitivity reaction to Depo-Provera.
    Zacest R; Cushway A; Haines C; Cox LW
    Med J Aust; 1982 Jan; 1(1):12. PubMed ID: 6460921
    [No Abstract]   [Full Text] [Related]  

  • 2. A case for concern?
    Gartland A
    Nurs Times; 1983 May 4-10; 79(18):10-1. PubMed ID: 6222288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depo Provera: a profile of current users.
    Jarman H; Kovacs GT; Westcott M
    Aust N Z J Obstet Gynaecol; 1990 Feb; 30(1):74-6. PubMed ID: 2140675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Depo-Provera public hearing.
    Dening FC
    Midwives Chron; 1983 Jul; 96(1146):246. PubMed ID: 6225940
    [No Abstract]   [Full Text] [Related]  

  • 5. Depo-Provera: a critical analysis.
    Minkin S
    Women Health; 1980; 5(2):49-69. PubMed ID: 6451987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug regulation in the United States and the United Kingdom: the Depo-Provera story.
    Richard BW; Lasagna L
    Ann Intern Med; 1987 Jun; 106(6):886-91. PubMed ID: 2953290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depo-Provera--ethical issues in its testing and distribution.
    Potts M; Paxman JM
    J Med Ethics; 1984 Mar; 10(1):9-20. PubMed ID: 6231379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of different doses of Depo Provera.
    Fotherby K; Koetsawang S; Mathrubutham M
    Contraception; 1980 Nov; 22(5):527-36. PubMed ID: 6451351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
    Polaneczky M; Liblanc M
    J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation.
    Pardthaisong T; Yenchit C; Gray R
    Contraception; 1992 Apr; 45(4):313-24. PubMed ID: 1387602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depo-provera: contraceptive risk?
    Rosenfield A
    Hastings Cent Rep; 1980 Apr; 10(2):4. PubMed ID: 6445344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis.
    Pardthaisong T
    J Biosoc Sci; 1984 Jan; 16(1):23-34. PubMed ID: 6230362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In utero exposure to steroid contraceptives and survival during infancy.
    Gray RH; Pardthaisong T
    Am J Epidemiol; 1991 Oct; 134(8):804-11. PubMed ID: 1835283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medroxyprogesterone (Depo Provera) and breast cancer.
    McCowan L
    N Z Med J; 1990 May; 103(889):225-6. PubMed ID: 2140436
    [No Abstract]   [Full Text] [Related]  

  • 16. In utero exposure to steroid contraceptives and outcome of pregnancy.
    Pardthaisong T; Gray RH
    Am J Epidemiol; 1991 Oct; 134(8):795-803. PubMed ID: 1835282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case for depo provera.
    Cooling H; Christopher E
    Health Visit; 1989 Oct; 62(10):320. PubMed ID: 2530193
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera.
    Kuhn L; Denny L; Pollack AE; Wright TC
    Contraception; 1999 Jun; 59(6):363-7. PubMed ID: 10518230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus.
    Petta CA; Faundes A; Dunson TR; Ramos M; DeLucio M; Faundes D; Bahamondes L
    Fertil Steril; 1998 Feb; 69(2):252-7. PubMed ID: 9496338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concerns voiced on Depo Provera.
    Sanders C
    RNAO News; 1986; 42(3):15, 22. PubMed ID: 2940668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.